Showing results (231-240 of 534) with videos related to
Sort By:
Pageof 54
American Journal of Clinical and Experimental Immunology|November 2, 2013
Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertensionLaura J Edwards, Basil Sharrack, Azza Ismail, et al.Neuroimmunomodulation|November 20, 2009
Expression of activity-dependent neuroprotective protein in the immune system: possible functions and relevance to multiple sclerosisManjit Braitch, Kiyokazu Kawabe, Mukanthu Nyirenda, et al.Brain Sciences|May 27, 2023
Investigating the Effect of Cigarette Smoking on Serum Uric Acid Levels in Multiple Sclerosis Patients: A Cross Sectional StudyMohammed Alrouji, Ali Manouchehrinia, Jehan Aram, et al.Clinical Immunology (Orlando, Fla.)|January 6, 2001
Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectivelyC S Constantinescu, B Hilliard, E Ventura, et al.BMC Biology|April 15, 2021
Experimental infection with the hookworm, Necator americanus, is associated with stable gut microbial diversity in human volunteers with relapsing multiple sclerosisTimothy P Jenkins, David I Pritchard, Radu Tanasescu, et al.Multiple Sclerosis and Related Disorders|December 20, 2024
Assessing disability progression using the WHODAS 2.0 in multiple sclerosis: Investigating clinical and socio-demographic factors in a large longitudinal cohort study (TONiC-MS)Richard M A Parker, Kate Tilling, Roger Mills, et al.Arthroscopy, Sports Medicine, and Rehabilitation|June 24, 2022
Hip Arthroscopy Procedural Volume Is Low Among Graduating Orthopaedic Surgery ResidentsSuleiman Y Sudah, Christopher R Michel, Matthew H Nasra, et al.Brain Sciences|October 28, 2023
Natalizumab Treatment for Relapsing Multiple Sclerosis Stabilises Normal-Appearing White Matter Microstructure: A One-Year Prospective Ultra-High-Field Quantitative Imaging StudyRadu Tanasescu, Olivier Mougin, I-Jun Chou, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2011
TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive functionMukanthu H Nyirenda, Lara Sanvito, Peter J Darlington, et al.Neurology and Therapy|September 16, 2023
Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T CellsRadu Tanasescu, Nanci Frakich, I-Jun Chou, et al.Pageof 54